Tetraneuron is a drug discovery company in treating brain and neurodegenerative conditions.
Tetraneuron has raised $5.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2025.
Tetraneuron's investors include GIMIC Ventures, Région Sud Investissement, Institut Valencià de Finances.
Tetraneuron is headquartered in Valencia, Spain.
Tetraneuron is a drug discovery company in treating brain and neurodegenerative conditions.
Tetraneuron is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Tetraneuron — Funding & Investors." VCBacked, December 9, 2025, https://www.vcbacked.co/company/tetraneuron. Accessed August 13, 2026.
VCBacked. (2025). Tetraneuron — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/tetraneuron
{{cite web |title=Tetraneuron — Funding & Investors |url=https://www.vcbacked.co/company/tetraneuron |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated